Human immunoglobulin preparations for intravenous or subcutaneous administration are
the cornerstone of treatment in patients with primary immunodeficiency diseases affecting …

Abstract Antibody-mediated rejection (AMR), including chronic AMR (cAMR), causes~ 50%
of kidney allograft losses each year. Despite attempts to develop well-tolerated and effective …

The kidney sessions of the 2017 Banff Conference focused on 2 areas: clinical implications
of inflammation in areas of interstitial fibrosis and tubular atrophy (i‐IFTA) and its relationship …

The success of heart transplantation in the 1980s was enabled by the ability to diagnose
rejection by transjugular right ventricular endomyocardial biopsy, a technique developed by …

Prezados colegas, Grandes avanços no diagnóstico, monitorização e tratamento da
Insuficiência Cardíaca (IC) foram observados nos últimos anos, com impactos reais na …

According to the humoral theory of transplantation, antibodies cause allograft rejection.
Publications are cited showing that antibodies:(1) cause hyperacute kidney rejection,(2) …

Reported are the reduction of anti-HLA antibody levels and improvement of transplant rates
by intravenous immunoglobulin (IVIG) in a randomized, double-blind, placebo-controlled …

Drug Therapy in the Heart Transplant Recipient | Circulation Science Volunteer Warning
signs SearchSearch Advanced Search Donate Circulation logo Hello Guest! MY ALERTS …

Background. Hyperacute rejection (HAR) and acute humoral rejection (AHR) remain
recalcitrant conditions without effective treatments, and usually result in graft loss …

In the last decade, transplantation across previously incompatible barriers has increasingly
become popular because of organ donor shortage, availability of better methods of detecting …